Introduction
The surgical treatment of aortic valve endocarditis remains a major
challenge in cardiac surgery (1).
Even though much progress has been made in terms of management and
pharmacological treatment, the ideal prosthesis to use in these cases
has not been found yet.
Some surgical groups started using the Sorin Perceval sutureless
bioprosthetic valve even in complicated scenarios such as aortic
endocarditis (2-5).
Up to now, only a few small series have been reported in the literature,
and no data are available regarding the mid-and long-term follow-up of
these patients.